Protein Sciences in Drug Discovery 2022
InSingulo AB
Where: 15 [Show on Floor Plan]
At InSingulo, we specialize in the characterization of drug interactions with complex targets at the single molecule level.
Our technology expands the current possibilities of the biosensing field, such as SPR, by providing interaction profiling measurements of small and large molecules on membrane proteins embedded in their native environment.
We enable drug screening programs against the largest group of therapeutic targets – membrane proteins.
Tel: +46735221409
Address: Pepparedsleden 1
BioVenture Hub

Presentations at Protein Sciences in Drug Discovery 2022

Staff Attending

Tim Kaminski
Co-founder and Chief Scientific Officer
InSingulo AB
Dr Matija Rojnik
Business Development Manager
InSingulo AB

Find out more...

To view the virtial stand - please login first LinkedIn URL